RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31578241http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31578241http://www.w3.org/2000/01/rdf-schema#comment"Tumor necrosis factor receptor 2 (TNFR2) is the alternate receptor for TNF and can mediate both pro- and anti-inflammatory activities of T cells. Although TNFR2 has been linked to enhanced suppressive activity of regulatory T cells (Tregs) in autoimmune diseases, the viability of TNFR2 as a target for cancer immunotherapy has been underappreciated. Here, we show that new murine monoclonal anti-TNFR2 antibodies yield robust antitumor activity and durable protective memory in multiple mouse cancer cell line models. The antibodies mediate potent Fc-dependent T cell costimulation and do not result in significant depletion of Tregs Corresponding human agonistic monoclonal anti-TNFR2 antibodies were identified and also had antitumor effects in humanized mouse models. Anti-TNFR2 antibodies could be developed as a novel treatment option for patients with cancer."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.org/dc/terms/identifier"doi:10.1126/scitranslmed.aax0720"xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Kumar S."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Jiao Y."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Qiu J."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Paragas V."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Xu L."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Zhang H."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Zhou Y."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Wong C."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Zhang K."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Tang J."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Marks J.D."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Richards J."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Muda M."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Qiao W."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Croft M."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Suchy J."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Craig G."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Lulo J."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Feau S."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Grabow S."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Kohli N."xsd:string
http://purl.uniprot.org/citations/31578241http://purl.uniprot.org/core/author"Jakubowski A."xsd:string